Why Sciatica Never Goes Away — And What the Research Says Actually Fixes It

If you have sciatica, you've probably been told some version of the same thing: rest, stretch, take anti-inflammatories, and if it gets bad enough, consider a cortisone injection. For most people, this advice comes from a doctor they trust. And for most people, it doesn't work — at least not permanently.

The pain comes back. Sometimes within weeks. Sometimes it spreads further down the leg. And every time it returns, the treatment cycle restarts: more stretching, another injection, another round of physical therapy.

This is not a fringe position. Research published in journals including Frontiers in Neurology, Pain, and The Spine Journal has increasingly pointed to chronic inflammation in the connective tissue surrounding the sciatic nerve — not just the disc above it — as a primary driver of persistent sciatica. When that inflammatory process is not resolved, the nerve continues to be irritated regardless of whether the structural compression is addressed.

Understanding why this happens — and what can actually interrupt the cycle — starts with how the sciatic nerve works and what happens when inflammation becomes chronic.

The Nerve, the Inflammation, and the Cycle Nobody Talks About

The sciatic nerve is the longest nerve in the human body, running from the lower spine through the glute, down the back of each leg, all the way to the foot. When something compresses or irritates it, the result is the familiar shooting pain, numbness, or burning sensation that characterizes sciatica.

The standard explanation is mechanical: a herniated disc presses on the nerve root, causing pain. Remove the pressure — through physical therapy, decompression, or surgery — and the pain should resolve.

But for roughly 40% of sciatica patients, the pain continues even after the structural issue is addressed. And for patients with chronic sciatica — pain lasting more than three months — the recurrence rate after cortisone injections is 60–80% within the first year.

Researchers studying this persistent-pain population have identified a process they call perineural neuroinflammation — sustained inflammation in the protective sheath surrounding the nerve root. Unlike acute inflammation, which resolves as part of normal healing, perineural inflammation can become self-sustaining, driven by the same inflammatory cytokines that originally developed in response to the injury.

The practical consequence: the nerve remains in a sensitized, irritated state even after the original structural cause is treated. And every inflammatory flare — from physical overexertion, poor posture, or even systemic stress — adds another layer to the problem.

Why Cortisone Injections Work — and Then Don't

Cortisone (corticosteroid) injections reduce inflammation rapidly and effectively. For many patients, this produces significant short-term pain relief — sometimes within days. Which is why they remain one of the most prescribed interventions for acute sciatica.

The problem is time. Corticosteroids suppress the inflammatory response systemically, but they do not address the structural or biological changes that are driving the neuroinflammatory cycle. Once the steroid clears the system, typically within 4–8 weeks, the inflammatory process resumes. Each subsequent injection has been shown in some studies to produce diminishing returns — and repeated injections near nerve tissue carry risks including nerve damage and connective tissue weakening. A Cochrane systematic review of 25 clinical trials confirmed that epidural corticosteroid injections offer only short-term relief with no significant long-term advantage.

What the Research Says About Nerve Recovery

The peripheral nervous system — the nerves outside the brain and spinal cord, including the sciatic nerve — has a documented capacity for regeneration. This is different from central nervous system injuries; peripheral nerves can and do regrow and restore function when the right conditions are present.

Those conditions center primarily on reducing the inflammatory environment around the nerve. Studies in Frontiers in Neurology and Neurochemistry International have documented measurable improvements in nerve conduction and pain scores in patients whose neuroinflammatory burden was reduced through targeted interventions — not just structural treatment.

Several plant-derived compounds have shown specific relevance in this research. Passiflora incarnata (Passionflower) extract has demonstrated GABAergic activity that reduces nerve sensitization. Corydalis rhizome contains DHCB, a compound studied for its effect on both inflammatory and neuropathic pain pathways — including sciatic nerve constriction models. Prickly Pear (Opuntia ficus-indica) extract shows anti-neuroinflammatory properties in multiple studies. California Poppy (Eschscholzia californica) has been studied for its role in nerve calming without the dependency profile of opioid-based compounds.

None of these is a single-compound solution. What researchers have explored is whether combining these ingredients in specific ratios — targeting multiple points in the neuroinflammatory cascade simultaneously — produces better outcomes than any single approach.

The short presentation below covers this research in full — including the specific protocol that has helped thousands of chronic sciatica sufferers interrupt the pain cycle when nothing else had worked.